BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 322.00
-23.00 (-6.67%)
Aug 26, 2026, 5:29 PM CET
BioArctic AB Employees
BioArctic AB had 141 employees as of March 31, 2026. The number of employees increased by 12 or 9.30% since the number was last reported on December 31, 2025.
Employees
141
Change
12
Growth
9.30%
Revenue / Employee
7.11M SEK
Profits / Employee
748.39K SEK
Market Cap
28.57B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 141 | 12 | 9.30% |
| Dec 31, 2025 | 129 | 22 | 20.56% |
| Dec 31, 2024 | 107 | 19 | 21.59% |
| Dec 31, 2023 | 88 | 27 | 44.26% |
| Dec 31, 2022 | 61 | 12 | 24.49% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Camurus AB | 316 |
| Hansa Biopharma AB | 131 |
| BioInvent International AB | 112 |
| Egetis Therapeutics AB | 44 |
| Saniona AB | 43 |
| Genovis AB (publ.) | 42 |
| Vicore Pharma Holding AB | 40 |
| SynAct Pharma AB | 8 |
BioArctic AB News
- 20 hours ago - BioArctic AB Earnings Call Transcript: Q2 2026 - Transcripts
- 20 hours ago - BioArctic AB Quarterly report: Q2 2026 - Filings
- 20 hours ago - BioArctic AB Slides: Q2 2026 - Filings
- 21 hours ago - BioArctic: Interim Report for the period April - June 2026 - PRNewsWire
- 2 days ago - Leqembi Iqlik® for initiation treatment launched in the US - PRNewsWire
- 7 days ago - BioArctic and Mesenkia enter oncology research collaboration - PRNewsWire
- 7 days ago - Invitation to presentation of BioArctic's second quarter report for April - June 2026 on August 26 at 9:30 a.m. CEST - PRNewsWire
- 4 weeks ago - Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026 - PRNewsWire